Literature DB >> 2423714

Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine.

W G Robertson, D S Scurr.   

Abstract

Various modifiers of the rate of crystallization of calcium oxalate (CaOx) known to be present in urine were studied in a continuous crystallizer system under conditions approximating those in whole urine. Of the small ions examined, magnesium and citrate were only weak inhibitors of the crystal growth rate and degree of agglomeration of CaOx within the urinary range of concentration of these ions. At and beyond the upper limit of the normal, however, both ions became much more active mainly through their ability to complex oxalate and calcium ions respectively. Pyrophosphate showed similar characteristics although its ability to act as an inhibitor at high concentrations was not due to complexation of calcium ions but to adsorption onto the crystal surface of the freshly generated CaOx crystals. The polyanionic inhibitors, chondroitin-4-sulphate, heparin and ribonucleic acid (RNA), also acted as adsorption inhibitors of growth and agglomeration. Of all the inhibitors tested RNA was the most active within the concentration range found in normal urine. Under the conditions of ionic strength employed, it was not possible to measure the effect of Tamm-Horsfall mucoprotein satisfactorily since it polymerized to form particles sufficiently large to interfere with the true crystal counts of CaOx in the test system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423714     DOI: 10.1016/s0022-5347(17)46084-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  In vitro calcium oxalate crystallisation methods.

Authors:  John P Kavanagh
Journal:  Urol Res       Date:  2006-01-14

Review 2.  Physico-chemical aspects of calcium stone formation.

Authors:  J M Baumann
Journal:  Urol Res       Date:  1990

3.  Studies on the crystallization of magnesium ammonium phosphate in urine.

Authors:  I Wall; H G Tiselius
Journal:  Urol Res       Date:  1990

Review 4.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  In vitro crystallisation systems for the study of urinary stone formation.

Authors:  W Achilles
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 6.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

7.  Acid Stimulation of the Citrate Transporter NaDC-1 Requires Pyk2 and ERK1/2 Signaling Pathways.

Authors:  Miriam Zacchia; Xuefei Tian; Enrica Zona; Robert J Alpern; Patricia A Preisig
Journal:  J Am Soc Nephrol       Date:  2018-04-20       Impact factor: 10.121

Review 8.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

9.  Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers.

Authors:  B Hess; U Meinhardt; L Zipperle; R Giovanoli; P Jaeger
Journal:  Urol Res       Date:  1995

Review 10.  Kidney stones.

Authors:  Saeed R Khan; Margaret S Pearle; William G Robertson; Giovanni Gambaro; Benjamin K Canales; Steeve Doizi; Olivier Traxer; Hans-Göran Tiselius
Journal:  Nat Rev Dis Primers       Date:  2016-02-25       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.